Mitiglinide Calcium

Mitiglinide calcium is a short‑acting oral antidiabetic agent of the “glinide” class, used (mainly in Asia) to improve postprandial glucose control in type 2 diabetes by rapidly stimulating insulin secretion from pancreatic β‑cells. It is grouped under the following drug class(es): Hypoglycemics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Mitiglinide calcium anhydrous and DTXSID90872410. Its PubChem CID is 5478927.

CAS No 145525-41-3
Molecular Formula C38H48CaN2O6
Molecular Weight 668.90 g/mol
Synonyms calcium bis((2S)-4-[(3aR,7aS)-1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl]-2-benzyl-4-oxobutanoate)

Frequently Asked Questions